Related Experiment Video
Updated: Jun 12, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
[Driveline Infection of Implantable Left Ventricular Assist Devices]
Haruki Tanaka1, Tatsuichiro Seto
1Department of Cardiovascular Surgery, Shinshu University, Matsumoto, Japan.
Abstract:
In Japan, the median waiting period from implantable left ventricular assist device( iLVAD) implantation to heart transplantation is 5.1 years, with driveline infections occurring in approximately 20% of cases within the first year. At our institution, we implemented the triple tunnel method and a structured care protocol to mitigate infection risk. This protocol includes meticulous monitoring, the use of sterilized kits, chlorhexidine, and caregiver training. Among 25 patients, driveline infections occurred in 12% (three cases), but none progressed to pump infections. Kaplan-Meier analysis showed infection-free rates of 100% at one year and 85% at three years, slightly surpassing national benchmarks. These outcomes highlight the importance of early detection, multidisciplinary follow-up, and consistent care in ensuring successful long-term management of iLVAD patients.
Related Concept Videos
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Endocarditis III: Medical Management
Bacterial Signaling
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

